This list of corporate research fronts from
Essential Science IndicatorsSM
is from the sixth bimonthly period of 2008, and covers areas in the
biological sciences. Source dates are January 31, 2003-December 31,
2008 (sliding 6-year period).
Research
Front Name
Percentage of corporate affiliations
Leading
corporation
ELECTROSPRAY-ATMOSPHERIC PRESSURE CHEMICAL IONIZATION
MASS SPECTROMETRY PLASMA MATRIX EFFECTS; QUANTITATIVE
LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY
36
Merck & Co., Inc.
VIRTUAL SCREENING USING PROTEIN-LIGAND DOCKING; FULLY
AUTOMATIC FLEXIBLE MOLECULAR DOCKING; SIMILARITY-BASED
VIRTUAL SCREENING USING 2D FINGERPRINTS
29
Schrodinger, LLC
EARLY DRUG DISCOVERY USING HIGH-RESOLUTION LIQUID
CHROMATOGRAPHY/QUADRUPOLE TIME-OF-FLIGHT MASS
SPECTROMETRY
29
Waters Corp.
HUMAN PROTEIN INTERACTIONS; GENE MENTION FINDING
EVALUATION; BIOCREATIVE TASKS; PROTEIN INTERACTION
INFORMATION
27
Mitre Corp.
DIPEPTIDYL PEPTIDASE-4 INHIBITOR VILDAGLIPTIN;
BETA-CELL FUNCTION; TYPE 2 DIABETES MELLITUS
INADEQUATELY CONTROLLED; TYPE 2 DIABETES FAILING
THIAZOLIDINEDIONE MONOTHERAPY
25
Merck & Co., Inc.
SUBOPTIMALLY CONTROLLED TYPE 2 DIABETES; TYPE 2
DIABETES PREVIOUSLY UNCONTROLLED; EXENATIDE EFFECTS;
MONOTHERAPY SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL
25
Amylin Pharmaceuticals, Inc.
NONINFLAMMATORY SYNTHETIC SIRNA; POTENT GENE SILENCING
IN-VIVO; SMALL INTERFERING RNA INHIBITS TUMOR GROWTH;
CHEMICALLY MODIFIED SMALL INTERFERING RNAS